CIFALDI, Loredana
 Distribuzione geografica
Continente #
NA - Nord America 116
EU - Europa 37
AS - Asia 32
AF - Africa 2
Totale 187
Nazione #
US - Stati Uniti d'America 115
IT - Italia 28
SG - Singapore 23
IN - India 6
SE - Svezia 3
AL - Albania 2
BG - Bulgaria 2
CN - Cina 2
TG - Togo 2
CA - Canada 1
DE - Germania 1
FI - Finlandia 1
ID - Indonesia 1
Totale 187
Città #
Rome 18
Singapore 17
Ashburn 12
Santa Clara 12
Woodbridge 12
Seattle 10
Fairfield 8
Houston 7
San Paolo di Civitate 6
Wilmington 5
Ann Arbor 3
Boston 3
Cambridge 3
Chandler 3
Lawrence 3
Princeton 3
Andover 2
Lomé 2
San Diego 2
Sofia 2
Tirana 2
Beijing 1
Boardman 1
Changsha 1
Des Moines 1
Jakarta 1
Norwalk 1
Plano 1
Solan 1
Toronto 1
Washington 1
Totale 145
Nome #
Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome 74
ERAP1 regulates natural killer cell function by controlling the engagement of inhibitory receptors 39
Role of endoplasmic reticulum aminopeptidases in health and disease: From infection to cancer 35
The Combination of Bioavailable Concentrations of Curcumin and Resveratrol Shapes Immune Responses While Retaining the Ability to Reduce Cancer Cell Survival 16
ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function 15
Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy 9
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors 7
DNAM-1 chimeric receptor-engineered NK cells: a new frontier for CAR-NK cell-based immunotherapy 5
null 1
Totale 201
Categoria #
all - tutte 924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 924


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 2 1 3 4 2 1 0 8
2020/202120 0 10 0 0 0 0 2 4 1 0 3 0
2021/202229 0 1 3 0 3 0 1 4 2 6 4 5
2022/202337 7 11 0 3 1 1 0 7 1 4 2 0
2023/202440 0 5 2 7 3 4 4 2 3 2 2 6
2024/202532 4 0 5 3 20 0 0 0 0 0 0 0
Totale 201